Position in ENTA
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$131,919
-$352,470 QoQ
Shares Held
10,445
-66.0% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,293,435,833 across 390 Biotechnology names. ENTA ranks #208 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in ENTA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $131,919 | 10,445 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $484,389 | 30,716 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $186,718 | 15,599 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $113,988 | 15,078 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $78,377 | 14,199 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $91,314 | 15,881 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $96,999 | 9,363 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $116,313 | 8,968 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $434,910 | 24,909 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $58,134 | 6,178 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $55,602 | 4,978 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $523,936 | 24,483 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $564,217 | 13,952 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $37,959 | 816 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $96,527 | 1,861 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $98,320 | 2,080 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,187,565 | 16,684 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,670,808 | 22,343 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $881,008 | 15,508 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $909,465 | 20,665 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $206,994 | 4,197 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,778,471 | 42,244 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $1,857,522 | 40,575 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $2,083,362 | 41,493 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,766,670 | 34,351 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||